Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTICAL-2: Neoadjuvant Cadonilimab plus mFOLFOXIRI in LARC
NCT05571644Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2023
- Primary completion
- Dec 2025
- Modality
- Bispecific Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cadonilimab in colorectal cancer (CRC), sponsored by Sun Yat-sen University. Started Jul 2023; status: recruiting.
02
Drugs
cadonilimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05571644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05571644.